APA

Reardon D. A., Dresemann G., Taillibert S., Campone M., van den Bent M., Clement P., Blomquist E., Gordower L., Schultz H., Raizer J., Hau P., Easaw J., Gil M., Tonn J., Gijtenbeek A., Schlegel U., Bergstrom P., Green S., Weir A. & Nikolova Z. (20100107). Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma. : British journal of cancer.

Chicago

Reardon D A, Dresemann G, Taillibert S, Campone M, van den Bent M, Clement P, Blomquist E, Gordower L, Schultz H, Raizer J, Hau P, Easaw J, Gil M, Tonn J, Gijtenbeek A, Schlegel U, Bergstrom P, Green S, Weir A and Nikolova Z. 20100107. Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma. : British journal of cancer.

Harvard

Reardon D. A., Dresemann G., Taillibert S., Campone M., van den Bent M., Clement P., Blomquist E., Gordower L., Schultz H., Raizer J., Hau P., Easaw J., Gil M., Tonn J., Gijtenbeek A., Schlegel U., Bergstrom P., Green S., Weir A. and Nikolova Z. (20100107). Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma. : British journal of cancer.

MLA

Reardon D A, Dresemann G, Taillibert S, Campone M, van den Bent M, Clement P, Blomquist E, Gordower L, Schultz H, Raizer J, Hau P, Easaw J, Gil M, Tonn J, Gijtenbeek A, Schlegel U, Bergstrom P, Green S, Weir A and Nikolova Z. Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma. : British journal of cancer. 20100107.